# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001062822-23-000007
Filing Date
2023-03-03
Accepted
2023-03-03 07:25:33
Documents
76
Period of Report
2022-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | lxrx-20221231.htm iXBRL | 10-K | 1685030
2 | EX-10.10 | exh1010officerrestrictedst.htm | EX-10.10 | 24639
3 | EX-23.1 | exh231ernstyoungconsent2022.htm | EX-23.1 | 3594
4 | EX-31.1 | exh311certificationofprinc.htm | EX-31.1 | 11840
5 | EX-31.2 | exh312certificationofprinc.htm | EX-31.2 | 11828
6 | EX-32.2 | exh321certificationofprinc.htm | EX-32.2 | 7495
12 |  | lxrx-20221231_g1.jpg | GRAPHIC | 91352
| Complete submission text file | 0001062822-23-000007.txt |  | 8004970

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | lxrx-20221231.xsd | EX-101.SCH | 74418
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | lxrx-20221231_cal.xml | EX-101.CAL | 41554
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | lxrx-20221231_def.xml | EX-101.DEF | 333278
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | lxrx-20221231_lab.xml | EX-101.LAB | 790278
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | lxrx-20221231_pre.xml | EX-101.PRE | 491305
70 | EXTRACTED XBRL INSTANCE DOCUMENT | lxrx-20221231_htm.xml | XML | 1032809

Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Filer) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30111 | Film No.: 23701633
SIC: 2834 Pharmaceutical Preparations